Outcomes in Alemtuzumab-Treated Patients With Thyroid Adverse Events: 6-Year Pooled CARE-MS Data (1509)Colin Dayan, Peter Senior, Sashiananthan Ganesananthan et al.|Neurology|2021Cited by 0